WHO Critical Priority Escherichia coli in Latin America: A One Health Challenge for a Post-Pandemic World-Reference-Cited by-同舟云学术

WHO Critical Priority Escherichia coli in Latin America: A One Health Challenge for a Post-Pandemic World

Published:2023 Issue: Volume: Page:1-32
ISSN:
Container-title:Trending Topics in Escherichia coli Research
language:
Short-container-title:

Author:

Lincopan Nilton,Fuentes-Castillo Danny,Espinoza-Muñoz Maria,Gonzales-Zubiate Fernando,Gonzales-Escalante Edgar,Maturrano Lenin,Vignoli Rafael,Di Conza Jose,Gutkind Gabriel

Publisher

Springer International Publishing

Link

https://link.springer.com/content/pdf/10.1007/978-3-031-29882-0_1

Reference169 articles.

1. Ahlstrom CA, Woksepp H, Sandegren L, Mohsin M, Hasan B, Muzyka D, Hernandez J, Aguirre F, Tok A, Söderman J, Olsen B, Ramey AM, Bonnedahl J (2022) Genomically diverse carbapenem resistant Enterobacteriaceae from wild birds provide insight into global patterns of spatiotemporal dissemination. Sci Total Environ 824:153632

2. Aizawa J, Neuwirt N, Barbato L, Neves PR, Leigue L, Padilha J, Pestana de Castro AF, Gregory L, Lincopan N (2014) Identification of fluoroquinolone-resistant extended-spectrum β-lactamase (CTX-M-8)-producing Escherichia coli ST224, ST2179 and ST2308 in buffalo (Bubalus bubalis). J Antimicrob Chemother 69(10):2866–2869

3. Albán MV, Núñez EJ, Zurita J, Villacís JE, Tamayo R, Sevillano G, Villavicencio FX, Calero-Cáceres W (2020) Canines with different pathologies as carriers of diverse lineages of Escherichia coli harbouring mcr-1 and clinically relevant β-lactamases in central Ecuador. J Glob Antimicrob Resist. 22:182–183

4. Alcedo K, Ruiz J, Ochoa TJ, Riveros M (2022) High prevalence of blaCTX-M in fecal commensal Escherichia coli from healthy children. Infect Chemother 54(1):59–69

5. Almeida AC, de Sá Cavalcanti FL, Vilela MA, Gales AC, de Morais MA Jr, Camargo de Morais MM (2012) Escherichia coli ST502 and Klebsiella pneumoniae ST11 sharing an IncW plasmid harbouring the bla(KPC-2) gene in an Intensive Care Unit patient. Int J Antimicrob Agents 40(4):374–376